Literature for PKSI-527 (S01.212 inhibitor)

(Topics flags: S Structure, I Inhibitor, P Specificity. To select only the references relevant to a single topic, click the link above. See explanation.)

2012
1. Gohda,K., Teno,N., Wanaka,K. and Tsuda,Y.
   Predicting subsite interactions of plasmin with substrates and inhibitors through computational docking analysis
   J Enzyme Inhib Med Chem27, 571-577. PubMed  Europe PubMed DOI  P  I
2001
2. Tada,M., Tsuda,Y., Wanaka,K., Hijikata-Okunomiya,A., Horie,N., Okamoto,U., Okamoto,S. and Okada,Y.
   Isolation of plasma kallikrein by high efficiency affinity chromatography and its characterization
   Biol Pharm Bull24, 520-524. PubMed  Europe PubMed DOI  I
3. Tomoo,K., Satoh,K., Tsuda,Y., Wanaka,K., Okamoto,S., Hijikata-Okunomiya,A., Okada,Y. and Ishida,T.
   Binding diversity of a noncovalent-type low-molecular-weight serine protease inhibitor and function of a catalytic water molecule: X-ray crystal structure of PKSI-527-inhibited trypsin
   J Biochem129, 455-460. PubMed  Europe PubMed  S  I
1999
4. Fukumizu,A., Tsuda,Y., Wanaka,K., Tada,M., Okamoto,S., Hijikata-Okunomiya,A. and Okada,Y.
   Amino acids and peptides. LIII. Synthesis and biological activities of some pseudo-peptide analogs of PKSI-527, a plasma kallikrein selective inhibitor: The importance of the peptide backbone
   Chem Pharm Bull (Tokyo)47, 1141-1144. PubMed  Europe PubMed  I
5. Okada,Y., Tsuda,Y., Tada,M., Wanaka,K., Hijikata-Okunomiya,A., Okamoto,U. and Okamoto,S.
   Development of plasma kallikrein selective inhibitors
   Biopolymers51, 41-50. PubMed  Europe PubMed DOI  I
1998
6. Tada,M., Wanaka,K., Okamoto,S., Okamoto,U., Nakaya,Y., Horie,N., Hijikata-Okunomiya,A., Tsuda,Y. and Okada,Y.
   Purification method for human plasma kallikrein by a new affinity chromatography
   Biol Pharm Bull21, 105-108. PubMed  Europe PubMed  I
7. Tsuda,Y., Wanaka,K., Tada,M., Okamoto,S., Hijikata-Okunomiya,A. and Okada,Y.
   Design of plasma kallikrein inhibitors: functional and structural requirements of plasma kallikrein inhibitors
   Chem Pharm Bull (Tokyo)46, 452-457. PubMed  Europe PubMed  I
1996
8. Katsuura,Y., Okamoto,S., Ohno,N. and Wanaka,K.
   Effects of a highly selective synthetic inhibitor of plasma kallikrein on disseminated intravascular coagulation in rats
   Thromb Res82, 361-368. PubMed  Europe PubMed DOI  I
1993
9. Teno,N., Wanaka,K., Okada,Y., Taguchi,H., Okamoto,U., Hijikata-Okunomiya,A. and Okamoto,S.
   Development of active center-directed plasmin and plasma kallikrein inhibitors and studies on the structure-inhibitory activity relationship
   Chem Pharm Bull (Tokyo)41, 1079-1090. PubMed  Europe PubMed  I
1992
10. Okamoto,S., Wanaka,K., Hijikata-Okunomiya,A., Okada,Y. and Katsuura,Y.
    A finding of highly selective synthetic inhibitor of plasma kallikrein; its action to bradykinin generation, intrinsic coagulation and experimental DIC
    Agents Actions Suppl38, 198-205. PubMed  Europe PubMed  I